Healthcare -
Biotechnology - NASDAQ - US
$ 16.5
0.671 %
$ 3.9 B
Market Cap
61.11
P/E
ADMA - STOCK-BASED COMPENSATION
Stock-based Compensation ADMA - ADMA Biologics, Inc.
6.19 M
LAST VALUE
33.18%
2 YEAR CAGR
0.00%
5 YEAR CAGR
21.42%
10 YEAR CAGR